Fortress Biotech, Inc. (FBIO)
NASDAQ: FBIO · Real-Time Price · USD
1.720
-0.020 (-1.15%)
Dec 20, 2024, 4:00 PM EST - Market closed

Fortress Biotech Revenue

Fortress Biotech had revenue of $14.63M in the quarter ending September 30, 2024, a decrease of -7.13%. This brings the company's revenue in the last twelve months to $81.50M, up 31.51% year-over-year. In the year 2023, Fortress Biotech had annual revenue of $84.51M with 11.58% growth.

Revenue (ttm)
$81.50M
Revenue Growth
+31.51%
P/S Ratio
0.36
Revenue / Employee
$438,177
Employees
186
Market Cap
47.48M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202384.51M8.77M11.58%
Dec 31, 202275.74M6.95M10.11%
Dec 31, 202168.79M23.19M50.86%
Dec 31, 202045.60M8.97M24.49%
Dec 31, 201936.63M9.75M36.26%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
iCAD, Inc. 18.94M
Omega Therapeutics 8.10M
Nutriband 2.02M
vTv Therapeutics 1.00M
Exicure 500.00K
Inovio Pharmaceuticals 203.41K
Revenue Rankings